Nationality: | German |
Fields: | Immunology |
Workplaces: | German Cancer Research Center |
Education: | Albert-Ludwig-University |
Alma Mater: | Max Planck Institute of Immunobiology and Epigenetics |
Thesis1 Title: | and |
Thesis2 Title: | )--> |
Thesis1 Url: | and |
Thesis2 Url: | )--> |
Thesis1 Year: | and |
Thesis2 Year: | )--> |
Doctoral Advisors: | )--> |
Hedda Wardemann is an immunologist and Professor in the Division of B cell immunology at the German Cancer Research Center in Heidelberg, Germany.[1]
Hedda Wardemann studied Biology at the Albert-Ludwig-University in Freiburg from 1992 until 1998. In 1998 she started as a doctoral researcher at the Max Planck Institute for Immunobiology, where she graduated in 2001.[2]
Wardemann moved to New York, United States, to work as a PostDoc in the laboratory of Michel C. Nussenzweig at the Rockefeller University until 2003. From 2003 to 2005, she held a position as Research Assistant Professor in Nussenzweigs group before she opened her junior research group at the Max Planck Institute for Infection Biology in Berlin, Germany.[3] Since 2014 Hedda Wardemann heads the B cell immunology division at the German Cancer Research Center in Heidelberg, Germany.
In 2019 she was elected as a member of the Academia Europaea.